DK0833842T3 - Hidtil ukendte peptider til anvendelse ved behandling af T-celle-formidlet nedbrydning af brusk ved autoimmune sygdomme - Google Patents

Hidtil ukendte peptider til anvendelse ved behandling af T-celle-formidlet nedbrydning af brusk ved autoimmune sygdomme

Info

Publication number
DK0833842T3
DK0833842T3 DK96920822T DK96920822T DK0833842T3 DK 0833842 T3 DK0833842 T3 DK 0833842T3 DK 96920822 T DK96920822 T DK 96920822T DK 96920822 T DK96920822 T DK 96920822T DK 0833842 T3 DK0833842 T3 DK 0833842T3
Authority
DK
Denmark
Prior art keywords
autoimmune diseases
cell mediated
treatment
cartilage degradation
cells
Prior art date
Application number
DK96920822T
Other languages
English (en)
Inventor
Gijsbertus Francisc Verheijden
Maria Helena Boots Anna
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Application granted granted Critical
Publication of DK0833842T3 publication Critical patent/DK0833842T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4725—Proteoglycans, e.g. aggreccan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
DK96920822T 1995-06-19 1996-06-17 Hidtil ukendte peptider til anvendelse ved behandling af T-celle-formidlet nedbrydning af brusk ved autoimmune sygdomme DK0833842T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP95201656 1995-06-19
PCT/EP1996/002605 WO1997000270A1 (en) 1995-06-19 1996-06-17 Novel peptides for use in treatment of t-cell mediated cartilage destruction in autoimmune diseases

Publications (1)

Publication Number Publication Date
DK0833842T3 true DK0833842T3 (da) 2000-04-03

Family

ID=8220392

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96920822T DK0833842T3 (da) 1995-06-19 1996-06-17 Hidtil ukendte peptider til anvendelse ved behandling af T-celle-formidlet nedbrydning af brusk ved autoimmune sygdomme

Country Status (21)

Country Link
EP (1) EP0833842B1 (da)
JP (1) JPH11507919A (da)
KR (1) KR19990022972A (da)
CN (1) CN1155617C (da)
AT (1) ATE185151T1 (da)
AU (1) AU704942B2 (da)
BR (1) BR9608626A (da)
CA (1) CA2221981A1 (da)
DE (1) DE69604492T2 (da)
DK (1) DK0833842T3 (da)
ES (1) ES2139363T3 (da)
GR (1) GR3031990T3 (da)
HU (1) HU223275B1 (da)
IL (1) IL118524A (da)
MX (1) MX9710508A (da)
NO (1) NO975968L (da)
NZ (1) NZ311022A (da)
PL (1) PL185258B1 (da)
TR (1) TR199701658T1 (da)
WO (1) WO1997000270A1 (da)
ZA (1) ZA965163B (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7488590B2 (en) 1998-10-23 2009-02-10 Amgen Inc. Modified peptides as therapeutic agents
MEP42108A (en) 1998-10-23 2011-02-10 Kiren Amgen Inc Dimeric thrombopoietin peptide mimetics binding to mp1 receptor and having thrombopoietic activity
US6660843B1 (en) 1998-10-23 2003-12-09 Amgen Inc. Modified peptides as therapeutic agents
IL132611A0 (en) 1999-10-27 2001-03-19 Yeda Res & Dev Synthetic genes and polypeptides and pharmaceutical compositions comprising them
US20050084967A1 (en) 2002-06-28 2005-04-21 Xcyte Therapies, Inc. Compositions and methods for eliminating undesired subpopulations of T cells in patients with immunological defects related to autoimmunity and organ or hematopoietic stem cell transplantation
US8008453B2 (en) 2005-08-12 2011-08-30 Amgen Inc. Modified Fc molecules

Also Published As

Publication number Publication date
CN1155617C (zh) 2004-06-30
NO975968D0 (no) 1997-12-18
HUP9802197A3 (en) 1999-06-28
NO975968L (no) 1997-12-18
TR199701658T1 (xx) 1998-06-22
CA2221981A1 (en) 1997-01-03
DE69604492D1 (de) 1999-11-04
EP0833842A1 (en) 1998-04-08
AU704942B2 (en) 1999-05-06
IL118524A0 (en) 1996-09-12
PL185258B1 (pl) 2003-04-30
GR3031990T3 (en) 2000-03-31
HU223275B1 (hu) 2004-04-28
WO1997000270A1 (en) 1997-01-03
ATE185151T1 (de) 1999-10-15
HUP9802197A2 (hu) 1999-02-01
CN1188483A (zh) 1998-07-22
KR19990022972A (ko) 1999-03-25
ES2139363T3 (es) 2000-02-01
JPH11507919A (ja) 1999-07-13
NZ311022A (en) 1999-11-29
PL324208A1 (en) 1998-05-11
ZA965163B (en) 1997-01-23
IL118524A (en) 2004-02-19
MX9710508A (es) 1998-03-31
BR9608626A (pt) 1999-06-15
AU6224696A (en) 1997-01-15
DE69604492T2 (de) 2000-04-13
EP0833842B1 (en) 1999-09-29

Similar Documents

Publication Publication Date Title
DE69636487D1 (de) Zusammensetzungen zur Immuntherapie und Diagnose von Tuberculosis
BR9506377A (pt) Peptídeo compreendendo uma subsequéncia de gp-39 hc proteina gp-39 hc ou peptideos composição farmacéutica uso da proteina gp-39 hc ou um ou mais dos peptídeos composição de diagnostico e processo de diagnóstico e kit de teste para a detecção de céçiças t auto-reativas ativadas
TR199802082T2 (xx) Otoantigen ve otoim�n hastal�klar�n im�noterapisinde kullan�lmak i�in otoantigen yap�sal olarak ili�kili proteinler.
NZ332427A (en) Peptides suitable for use in antigen specific immunosuppressive therapy
DK0833842T3 (da) Hidtil ukendte peptider til anvendelse ved behandling af T-celle-formidlet nedbrydning af brusk ved autoimmune sygdomme
NZ500216A (en) Beta-amyloid peptide-binding proteins and pharmaceutical use
ES2151557T3 (es) Corpusculos de proteinas de estaño, estanniocalcina.
TR200100175T2 (tr) Otoimmün hastalıkların immünoterapisinde kullanılmak üzere yeni peptitler.
DE69631624D1 (de) Antikörper gegen menschliches restrictin
ECSP993062A (es) Nuevos peptidos para ser usados en una terapia de tolerancia inducida para impedir las alteraciones autoinmunes, en particular, artritis reumatoidea
HUP0301111A2 (hu) Potenciálisan immundomináns acetilkolin-receptor oligopeptideket tartalmazó gyógyszerkészítmények és alkalmazásuk
DK1041997T3 (da) Anvendelse af citrullinerede peptider afledt af filaggrin til behandling af autoimmunsygdomme
NZ505580A (en) Method of treating immunodeficiences using neutrokine alpha
UA23902A (uk) Пристрій для психологічних досліджень